US-based 22nd Century Group has acquired RX Pharmatech (RXP), a leading cannabinoid distributor in the UK that offers 1,276 food applications. The deal includes a cash and stock payment of $650,000 (approximately RMB 4.41 million) upfront, as well as equity payouts over a three-year period based on revenue.
The acquisition will ensure direct entry of our CBD products into the European market," said Mish, CEO of 22nd Century Group. "RXP has developed efficient application and compliance plans, ensuring approval for 1,276 new food applications for CBD products in the first round. As we move forward, we look forward to leveraging their leadership team's rich experience in the cannabis industry and strong relationships with UK and EU regulatory agencies.
Mish continued to say, "We expect that the acquisition of RXP will enhance the group's operational efficiency, leading to improvements in revenue and gross profit margins. In particular, by adding RXP to our recently opened distribution channels in the Netherlands, we will be able to expand our business scale and seize a larger market share in the ever-growing European consumer goods market.
RXP offers a range of products, including CBD isolates, as well as various finished products such as chewing gum, oil, droppers, candy, tinctures, sprays, and capsules.
The 22nd Century Group is a brand company that sells VLN cigarettes, holds valuable biotechnology intellectual property (IP), and offers highly specialized factory production lines in global end markets.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
